Results Wire: US FDA Advisory Committee Discusses “Streamlined” Clinical Trial Development for Antibacterial Products – DEC 4, 2014 (AIDAC)

On Thursday, December 4, 2014 the Anti-Infective Drugs Advisory Committee (AIDAC) discussed issues related to clinical development programs and clinical trial designs for antibacterial products for the treatment of patients with serious bacterial infections for which there are limited or no therapeutic options. They reviewed ways in which to streamline development.

See the SAC Tracker Report